Home About Us Pipeline News Investors Contacts Careers




Puma Biotechnology, Inc. Corporate Fact Sheet


RECENT NEWSCURRENT EVENTSCLINICAL TRIALS



February 15, 2018 - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results
Read

February 7, 2018 - Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference
Read

February 1, 2018 - Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Greater China
Read

January 31, 2018 - Puma Biotechnology Announces Publication of Results from Phase II SUMMIT ‘Basket’ Trial Evaluating Neratinib in HER2 and HER3 Mutant Cancers - Data published online today in Nature -
Read

January 30, 2018 - Puma Biotechnology and Medison Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Israel
Read

January 29, 2018 - Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Read

January 23, 2018 - Puma Biotechnology Announces Results of CHMP Oral Explanation for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer
Read

December 14, 2017 - Puma Biotechnology Added to NASDAQ Biotechnology Index
Read

December 13, 2017 - Puma Biotechnology Announces Meeting of Scientific Advisory Group on Oncology in Europe to Review Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer
Read

December 12, 2017 - Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
Read

December 11, 2017 - Puma Biotechnology Announces Positive Outcome of European Opposition Proceedings
Patent Claims for Extended Adjuvant Treatment Upheld
Read

December 6, 2017 - Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 San Antonio Breast Cancer Symposium
Read

March 1, 2018 - Puma Biotechnology 4Q-2017 Financial Results Conference Call
More

February 14, 2018 - LEERINK Partners 7th Annual Global Healthcare Conference
More

December 5 – 9, 2017 - San Antonio Breast Cancer Symposium
More

November 15, 2017 - Stifel 2017 Healthcare Conference
More

November 9, 2017 - Puma Biotechnology 3Q-2017 Financial Results
More

November 7, 2017 - Credit Suisse Healthcare Conference
More

Puma-Sponsored Trials
Investigator-Sponsored Trials




Annual Report

2016 Annual Report

 Annual Report Archives



Contact

Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
info@pumabiotechnology.com